checkAd

     217  0 Kommentare Alpine Immune Sciences Announces Amendment of Acazicolcept Option and License Agreement with AbbVie - Seite 3

    Source: Alpine Immune Sciences, Inc.

    Lesen Sie auch


    The Alpine Immune Sciences Stock at the time of publication of the news with a raise of +3,76 % to 17,95EUR on Lang & Schwarz stock exchange (21. Dezember 2023, 22:20 Uhr).

    Business Wire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von Business Wire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Alpine Immune Sciences Announces Amendment of Acazicolcept Option and License Agreement with AbbVie - Seite 3 Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced today that the Company has amended the previously announced …